The silent pandemic of antibiotic resistance

  22 January 2021

Southern Africa has long been burdened by the scourges of HIV, tuberculosis and malaria, but a new and more silent pandemic has now taken hold: antimicrobial resistance.

In my hospital ward, we recently admitted a 39-year old man with multi-drug resistant tuberculosis and kidney failure who had stopped his HIV treatment some months before. His tuberculosis was treated with seven different drugs and started to respond but after eight days his temperature spiked, his blood pressure dropped and we identified extensively drug-resistant Klebsiella pneumoniae bacteria in his blood. The only option was colistin, an antibiotic of last resort, but he continued to deteriorate and succumbed to overwhelming infection.

Further reading: Financial Times
Author(s): Marc Mendelson
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!